Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-19 01:05 CEST (UTC+2h)

IP retention EU regulatory requirements [Regulatives / Guidelines]

posted by manusyriac - India, 2018-03-08 10:20  - Posting: # 18505
Views: 439

Hi All,

I would like to seek your help in getting your thoughts on the EU regulatory requirements on the investigational medicinal product retention at sponsor manufacturing sites. Especially my focus area is the quantity of IP to be stored at manufacturing site.

Please guide me.

Regards
Manu

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,384 posts in 3,905 threads, 1,172 registered users;
online 14 (1 registered, 13 guests [including 9 identified bots]).

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed